netFormulary

North East and North Cumbria
ICS Formulary

back

5 Infections

05-01-02-01 Cephalosporins

Cefalexin

Formulary

Cefazolin

Formulary

1g and 2g vials
- Approved as an alternative to flucloxacillin in patients with non-immediate penicillin allergy or in those who cannot tolerate flucloxacillin or alternatives
- To be used on the advice of microbiology and ID physicians only.

Cefiderocol Fetcroja^®

Formulary

1g powder for concentrate for solution for infusion
- approved for the treatment of infections with gram negative aerobic bacteria in patients with limited treatment options. Only to be used on the advice of mricbiology and ID physicians

Cefixime

Formulary

Restricted for use on microbiology/infectious diseases advice, or as agreed in Trust Guidelines.
200mg tablets
100mg in 5ml paediatric suspension: also approved for the prevention of irinotecan induced diarrhoea, specialist use only .

Cefotaxime

Formulary

Restricted for use on microbiology/infectious diseases advice, or as agreed in Trust Guidelines.

Ceftaroline

Formulary

Restricted for use on microbiology/infectious diseases advice, or as agreed in Trust Guidelines.

Ceftazidime

Formulary

Ceftobiprole

Formulary

Approved for the treatment of hospital acquired pneumonia and other infections on the advice of microbiology/infectious disease physicans.

Ceftolozane & tazobactam

Formulary

Approved for use in multiple antibiotic resistant strains of enterobacteriaceae, pseudomonas and acinetobacters on the advice of microbiology/infectious disease physicians.

Ceftriaxone

Formulary

Restricted for use on microbiology/infectious diseases advice, or as agreed in Trust Guidelines.
Approved for use in primary care (i.e. care homes) to treat patients with conditions such as UTIs and pneumonia, at risk of sepsis in line with local guidance and microbiology input

Cefuroxime

Formulary

Ceftazadime / avibactam Zavicefta^®

Formulary

2.5g injection
Approved for use only on the advice of Microbiology/Infectious Diseases for the treatment of infections with carbapenemase-producing organisms for which treatment options are very limited, toxic and not particularly effective.

Links